Product logins

Find logins to all Clarivate products below.


Heart Valve Devices – Market Insights – Latin America (Supplemental)

The Latin American heart valve device market will be driven by expanding patient pool and availability of several new THV devices. Rapid adoption of these devices and positive results from clinical trials supporting their use will drive strong growth in the Latin American heart valve device market over the forecast period. Furthermore, novel devices and device types will continue to emerge, expanding patient populations and driving continued growth in the market.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for heart valve devices in Latin America from 2019 through 2032.

Table of contents


Related Medtech Insights Reports

Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Asia Pacific
The Asia Pacific EP mapping and ablation device market will experience strong growth through 2034, driven by rising procedure volumes, new product launches, increasing prevalence of cardiac…
Report
Aortic Repair Devices – Market Insights – United States
The US aortic repair device market will grow moderately during upcoming years, driven by the uptake of innovative stent grafts and the positive clinical evidence that supports their adoption. The…
Report
Deep Venous Disease Treatment Devices – Market Insights – Global
The uptake of innovative higher-priced powered thrombectomy devices, together with the increasing use of PE treatment procedures—both supported by favorable clinical data—will drive strong…
Report
Dialysis Access Treatment Devices – Market Insights – United States
The US dialysis access treatment device market will grow at a moderate rate due to the increasing adoption of innovative products, positive clinical data, and rising ASPs of specific devices like…
Report
Cardiac Rhythm Management Devices – Market Insights – Japan
The Japanese CRM device market will grow over the forecast period. The introduction of novel products—such as the Aurora EV-ICD and dual-chamber leadless pacemakers—and favorable reimbursement…